Tunisian children reference for body mass index and prevalence of obesity

Hayet Ben Amara1, Jabrane Jelidi, Radhia Bouguerra

  • 1National Institut of Nutrition, Tunis, Tunisia.

La Tunisie Medicale
|May 29, 2009
PubMed

Insights

Childhood obesity is rising globally. This study analyzed Tunisian children

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Growth Monitoring

Background:

  • Global rise in childhood obesity necessitates regional data.
  • Limited population-based surveys in North Africa and the Middle East.

Purpose of the Study:

  • Establish body mass index (BMI) percentiles for Tunisian children.
  • Estimate childhood obesity and overweight prevalence using international references.

Main Methods:

  • Utilized data from the Tunisian National Nutrition Survey.
  • Included 3885 children and adolescents in a cross-sectional study.
  • Applied NHANES I, IOTF, and Rolland Cachera criteria for analysis.

Main Results:

  • Mean BMI: 16.63 ± 2.58 kg/m² (boys), 17.36 ± 3.52 kg/m² (girls).
  • BMI increased with age, earlier in girls (10 yrs) than boys (13-14 yrs).
  • Prevalence varied: low (<5%) by NHANES I/IOTF, high (3-11%) by Rolland Cachera.

Conclusions:

  • Obesity prevalence in Tunisian children varied by reference standard in 1996.
  • Healthy lifestyle promotion is key for long-term, cost-effective obesity prevention.
  • Regular monitoring programs are essential for public health.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...